Letters by company

Halozyme Therapeutics, INC.

1 letter discussing HALO. Everything written about it on this site is on its ticker page.

Renaissance Investment Management — Large Cap Growth Large Cap Growth Quarter-End Review Large Cap Growth added SanDisk as an AI-driven NAND flash-memory beneficiary and sold Tapestry as Coach-led improvement looked increasingly reflected in valuation while revenue and margin prospects weakened. Microsoft, Halozyme and Meta benefited from operating momentum and AI product development, while KLA, Applied Materials and Lam Research fell amid a rotation away from AI-linked semiconductor stocks. 3Q2026 AMAT $260BHALO $15BKLAC $193B